STOCK TITAN

Evolent Health to Participate in the CG Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Evolent Health, Inc. (NYSE: EVH) will participate in the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 4:30 p.m. ET. CEO Seth Blackley and VP of Investor Relations Seth Frank will lead investor meetings and present at the event held in Boston, Massachusetts.

A live audio webcast will be accessible on Evolent's Investor Relations website.

Evolent Health provides clinical solutions aimed at improving health care delivery.

Positive
  • None.
Negative
  • None.

WASHINGTON, Aug. 10, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley and Vice President, Investor Relations Seth Frank will conduct investor meetings and host a presentation at the Canaccord Genuity 42nd Annual Growth Conference at The Intercontinental Boston Hotel, Boston, Mass., on Wednesday, August 10, 2022 at 4:30 p.m. ET.

A live audio-only webcast and replay for this event will be available on the Investor Relations section of Evolent's website at http://ir.evolenthealth.com/

Evolent Health Logo (PRNewsfoto/Evolent Health)

About Evolent Health 
Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Our solutions encompass total cost of care management, specialty care management and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolenthealth.com.

Contacts:

Seth R. Frank
Vice President, Investor Relations
Evolent Health, Inc.
sfrank@evolenthealth.com
571-895-3919 (W)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-health-to-participate-in-the-cg-growth-conference-301603595.html

SOURCE Evolent Health

FAQ

What is the date and time of Evolent Health's presentation at the Canaccord Genuity Growth Conference?

Evolent Health will present on August 10, 2022, at 4:30 p.m. ET.

Who will represent Evolent Health at the Canaccord Genuity Growth Conference?

CEO Seth Blackley and VP of Investor Relations Seth Frank will represent Evolent Health.

Where is the Canaccord Genuity Growth Conference being held?

The conference will take place at The Intercontinental Boston Hotel in Boston, Massachusetts.

How can I access Evolent Health's presentation from the conference?

A live audio-only webcast and replay will be available on Evolent's Investor Relations website.

What does Evolent Health specialize in?

Evolent Health specializes in delivering clinical and administrative solutions to improve health care.

Evolent Health, Inc

NYSE:EVH

EVH Rankings

EVH Latest News

EVH Stock Data

1.44B
116.21M
3.95%
116.7%
9.37%
Health Information Services
Services-management Services
Link
United States of America
ARLINGTON